Company profile WINT
After 39 days of this quarter the interest is at 23.0. Based on that we can calculate that during remaining 52 days it will total up to 54.0. Windtree Therapeutics expected interest is significantly lower compared to same quarter last year (-78.9%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 95 | 214 125.3% QoQ | 63 -70.6% QoQ | 20 -68.3% QoQ |
| 2020 | 117 23.2% YoY 485.0% QoQ | 278 29.9% YoY 137.6% QoQ | 123 95.2% YoY -55.8% QoQ | 88 340.0% YoY -28.5% QoQ |
| 2021 | 291 148.7% YoY 230.7% QoQ | 167 -39.9% YoY -42.6% QoQ | 76 -38.2% YoY -54.5% QoQ | 110 25.0% YoY 44.7% QoQ |
| 2022 | 251 -13.7% YoY 128.2% QoQ | 197 18.0% YoY -21.5% QoQ | 135 77.6% YoY -31.5% QoQ | 202 83.6% YoY 49.6% QoQ |
| 2023 | 256 2.0% YoY 26.7% QoQ | 166 -15.7% YoY -35.2% QoQ | 136 0.7% YoY -18.1% QoQ | 68 -66.3% YoY -50.0% QoQ |
| 2024 | 23 -91.0% YoY -66.2% QoQ | - | - | - |
The average 5 years interest of Windtree Therapeutics was 11.79 per week. The last year interest of Windtree Therapeutics compared to the last 5 years has changed by -4.75%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 24.78%.
After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0. Windtree Therapeutics stock expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 0 |
| 2019 | 187 inf% QoQ | 48 -74.3% QoQ | 87 81.2% QoQ | 58 inf% YoY -33.3% QoQ |
| 2020 | 205 9.6% YoY 253.4% QoQ | 181 277.1% YoY -11.7% QoQ | 69 -20.7% YoY -61.9% QoQ | 170 193.1% YoY 146.4% QoQ |
| 2021 | 34 -83.4% YoY -80.0% QoQ | 225 24.3% YoY 561.8% QoQ | 138 100.0% YoY -38.7% QoQ | 149 -12.4% YoY 8.0% QoQ |
| 2022 | 26 -23.5% YoY -82.6% QoQ | 72 -68.0% YoY 176.9% QoQ | 32 -76.8% YoY -55.6% QoQ | 77 -48.3% YoY 140.6% QoQ |
| 2023 | 141 442.3% YoY 83.1% QoQ | 129 79.2% YoY -8.5% QoQ | 175 446.9% YoY 35.7% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of Windtree Therapeutics stock was 8.47 per week. The last year interest of Windtree Therapeutics stock compared to the last 5 years has changed by 9.92%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 37.11%.
There is not enough data for istaroxime clinical trial to provide analysis
There is not enough data for istaroxime clinical trial to provide correlation calculation
There is not enough data for istaroxime clinical trial to provide analysis
There is not enough data for AEROSURF clinical trial to provide analysis
There is not enough data for AEROSURF clinical trial to provide correlation calculation
There is not enough data for AEROSURF clinical trial to provide analysis
There is not enough data for Surfaxin clinical trial to provide analysis
There is not enough data for Surfaxin clinical trial to provide correlation calculation
There is not enough data for Surfaxin clinical trial to provide analysis
There is not enough data for Rostafuroxin clinical trial to provide analysis
There is not enough data for Rostafuroxin clinical trial to provide correlation calculation
There is not enough data for Rostafuroxin clinical trial to provide analysis
There is not enough data for SERCA2a activator preclinical trial to provide analysis
There is not enough data for SERCA2a activator preclinical trial to provide correlation calculation
There is not enough data for SERCA2a activator preclinical trial to provide analysis
There is not enough data for Windtree Therapeutics headquarters to provide analysis
There is not enough data for Windtree Therapeutics headquarters to provide correlation calculation
There is not enough data for Windtree Therapeutics headquarters to provide analysis
There is not enough data for Windtree Therapeutics company information to provide analysis
There is not enough data for Windtree Therapeutics company information to provide correlation calculation
There is not enough data for Windtree Therapeutics company information to provide analysis